American Gastroenterological Association institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease

被引：503

作者：

Lichtenstein, GR

Abreu, MT

Cohen, R

Tremaine, W

机构：

[1] Univ Penn, Sch Med, Hosp Univ Penn, Philadelphia, PA 19104 USA

[2] Mt Sinai Med Ctr, Mt Sinai Sch Med, New York, NY 10029 USA

[3] Univ Chicago, Sch Med, Univ Chicago Hosp, Chicago, IL 60637 USA

[4] Mayo Clin, Coll Med, Rochester, MN USA

来源：

GASTROENTEROLOGY | 2006年 / 130卷 / 03期

关键词：

D O I：

10.1053/j.gastro.2006.01.048

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

[No abstract available]

引用

页码：940 / 987

页数：48

共 319 条

[91] Granulomatous bronchiolitis with necrobiotic pulmonary nodules in Crohn's disease [J].

Freeman, HJ ;

Davis, JE ;

Prest, ME ;

Lawson, EJ .

CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2004, 18 (11) :687-690

[92] Randomized, double-blind, one-year study of the safety and tolerability of cyclosporine microemulsion compared with conventional cyclosporine in renal transplant patients [J].

Frei, UA ;

Neumayer, HH ;

Buchholz, B ;

Niese, D ;

Mueller, EA .

TRANSPLANTATION, 1998, 65 (11) :1455-1460

[93] Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management [J].

Gardam, MA ;

Keystone, EC ;

Menzies, R ;

Manners, S ;

Skamene, E ;

Long, R ;

Vinh, DC .

LANCET INFECTIOUS DISEASES, 2003, 3 (03) :148-155

[94]

Gardiner S. J., 2000, Adverse Drug Reactions and Toxicological Reviews, V19, P293

[95]

George J, 1996, AM J GASTROENTEROL, V91, P1711

[96] The molecular complexity of glucocorticoid actions in inflammation - a four-ring circus [J].

Goulding, NJ .

CURRENT OPINION IN PHARMACOLOGY, 2004, 4 (06) :629-636

[97] Oral budesonide as maintenance treatment for Crohn's disease: A placebo-controlled, dose-ranging study [J].

Greenberg, GR ;

Feagan, BG ;

Martin, F ;

Sutherland, LR ;

Thomson, ABR ;

Williams, N ;

Nilsson, LG ;

Persson, T .

GASTROENTEROLOGY, 1996, 110 (01) :45-51

[98] ORAL BUDESONIDE FOR ACTIVE CROHNS-DISEASE [J].

GREENBERG, GR ;

FEAGAN, BG ;

MARTIN, F ;

SUTHERLAND, LR ;

THOMSON, ABR ;

WILLIAMS, CR ;

NILSSON, LG ;

PERSSON, T ;

BAIN, V ;

CHERRY, R ;

FEDORAK, R ;

LALOR, E ;

SHERBANIUK, R ;

YACYSHYN, B ;

KIERDEKIS, P ;

BAILEY, R ;

MEYER, D ;

FREEMAN, H ;

DAWS, P ;

HOLLAND, S ;

BUYTENDORP, M ;

WHITTAKER, S ;

CHANG, A ;

SUTHERLAND, L ;

HERSHFIELD, N ;

MACCANNELL, K ;

MEDDING, J ;

PRICE, L ;

SHAFFER, E ;

RACICOT, N ;

BASS, S ;

BRIDGES, R ;

BLUSTEIN, P ;

LAY, T ;

VANROSENDAAL, G ;

WATSON, M ;

WILLIAMS, CN ;

VANZANTEN, V ;

LEDDIN, D ;

FALKENHAM, J ;

TANTON, R ;

HUMAN, P ;

TURNBALL, G ;

SCHEP, G ;

WOOLNOUGH, J ;

DALLAIRE, C ;

ROSSEAU, B ;

BERNARD, F ;

DUBE, R ;

PARE, P .

NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (13) :836-841

[99]

GREENSTEIN AJ, 1985, CANCER, V56, P2914, DOI 10.1002/1097-0142(19851215)56:12<2914::AID-CNCR2820561232>3.0.CO

[100]

2-J

← 5 6 7 8 9 10 11 12 13 14 →